PAHC PHIBRO ANIMAL HEALTH CORP CLASS A
Health Care · Russell 2000
Next earnings: Wed 3 Feb 2027 · estimated
What 5 analyst firms say about PHIBRO ANIMAL HEALTH CORP CLASS A: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
3 rated views · 5 analyst/firm records · 5 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 5 analysts in the last 6 months (3)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 5 analysts in the last 6 months (3)
Recent analyst activity · last 90 days
Our tracked history has 2 reports on PAHC from 2 analyst firms in the last 90 days (5 firms in the past year).
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Citigroup | Daniel Grosslight | Hold | 14 May 2026 | 44.00 USD |
| JPMorgan | Ekaterina Knyazkova | Buy | 7 Nov 2025 | 50.00 USD |
| Morgan Stanley | Unnamed analyst | — | 6 Feb 2026 | 49.00 USD |
| Weiss Ratings | Unnamed analyst | — | 11 Sep 2026 | — |
| Data feed RESEARCH | Research Team | Buy | 18 Sep 2026 | Conflicting reports · excluded |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:10 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.